Merck & Co., Inc. (BMV:MRK)
Mexico
· Delayed Price · Currency is MXN 1,821.88
-11.59 (-0.63%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States Revenue | 35.56B | 32.28B |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East and Africa Revenue | 14.17B | 14.04B |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Revenue | 3.43B | 3.46B |
Log In |
Log In |
Log In | Upgrade
|
| China Revenue | 2.44B | 5.49B |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific (other than China and Japan) Revenue | 3.00B | 3.06B |
Log In |
Log In |
Log In | Upgrade
|
| Japan Revenue | 2.84B | 3.28B |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Revenue | 2.80B | 2.56B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 1.00M | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 64.24B | 64.17B |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Pharmaceutical Revenue | 57.34B | 57.40B |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Revenue | 6.25B | 5.88B |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Revenue | 648.00M | 891.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 64.24B | 64.17B |
Log In |
Log In |
Log In | Upgrade
|
EBT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Pharmaceutical Segment Profit | 45.15B | 44.53B |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Segment Profit | 2.10B | 1.94B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Profit | -25.43B | -26.54B |
Log In |
Log In |
Log In | Upgrade
|